Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: EUIPO deputy eyes top role, Nokia and Samsung agree 5G licence

Nokia This week-comp.jpg

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

EUIPO deputy chief announces bid for top job

EUIPO second-in-command Andrea Di Carlo will run to succeed Christian Archambeau as executive director later this year, he confirmed on Saturday, January 21.

Di Carlo, who has served as deputy executive director since 2019, said in a LinkedIn post that applying for the job was a natural step.

Click here to read the full article.

Nokia, Samsung agree fresh 5G patent licence

Samsung has agreed to pay Nokia for access to 5G patents as part of a cross-licensing deal announced on January 23.

The new agreement covers the period from January 1 and replaces a deal that expired at the end of 2022.

Click here to read the full article.

PTAB reveals reasons for cancelling Novartis patent

The Patent Trial and Appeal Board released its reasoning for cancelling a Novartis patent after a petition from Regeneron on Friday, January 20.

The board made the decision on October 25 2022, but the final written decision was, until Friday, only available to the board and both parties.

Click here to read the full article.

Other articles published by Managing IP this week include:

Five patent trends to watch in Australia in 2023

India bill decriminalising IP offences goes down badly

UKIPO faces copyright owner pushback over AI revolution

Counsel: IP associations must get tough on e-commerce liability

Lenovo infringed InterDigital 4G patent, Court of Appeal rules

Dutch court denies Nokia in latest Oppo twist

Counsel demand bad faith to be used in trademark oppositions

Weekly take: IP juniors’ chance at first-team action long overdue

Elsewhere in IP

UKIPO costs

The UKIPO updated its position on recoverable costs in proceedings on Wednesday, January 25, the first update since 2016. The changes include a £600 ($724) cap on fast-track opposition proceedings. The new scale will apply to proceedings commenced on or after February 1 2023.

BMS lines up AZ

In a lawsuit filed on Monday, January 23, BMS alleged that AstraZeneca’s new CTLA-4 inhibitor Imjudo (rovelizumab), which was approved in the US last year, infringes a pair of patents linked to BMS’s cancer drug Yervoy (ipilimumab). The lawsuit was filed at the District Court for the District of Delaware.

EPO quality meeting

The EPO is to meet with members of the Industry Patent Quality Charter (IPQC) on February 3, the group confirmed on Wednesday, January 25. The IPQC, which has been hankering for a meeting with the EPO, is keen to discuss specific examples of where the quality of granted patents did not meet its expectations. Earlier this month, Managing IP reported that the EPO had agreed to meet the group.

IP5 growth

The world's five largest IP offices granted 1.5 million patents in 2021 (the latest year for which statistics are available), the EPO reported on Tuesday, January 24. The figure is 10% up on the previous year. The report is an annual compilation of patent statistics published by the EPO, the JPO, the KIPO, the CNIPA and the USPTO.

SME help

A call for applications to the EUIPO’s SME Fund 2023 opened on Tuesday, January 23. The SME Fund is a grant scheme designed to help EU SMEs to protect their intellectual property rights.

Rolex rantings

Finally, in yet another David v Goliath trademark battle, Rolex has asked a Devon-based children's clock business to rebrand. According to a BBC report on Thursday, January 19, Rolex wrote to Oyster & Pop and claimed that people may link the educational clocks with its own Oyster Perpetual brand.

That's it for today, see you again next week.

more from across site and ros bottom lb

More from across our site

Patient groups and generics makers may have to bear the brunt of India’s latest attempt at patent reform
Each week Managing IP speaks to a different IP lawyer about their life and career
Paolo Tavolato, who will share the role, said private equity support would help the IP consultancy achieve its ambitious M&A plans
Cyril Amarchand Mangaldas has hired former Anand & Anand partner Swati Sharma and hopes to compete with specialist IP firms
Rapporteur-Judge András Kupecz ruled that education and training weren’t legitimate reasons for a member of the public to access documents
Searches for comparison prior art will be a little easier, but practitioners will have to put more thought into claim construction and design patent titles
The Helsinki local division rejected AIM Sport’s request for a preliminary injunction in a dispute with rival Supponor
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
The FTC’s plans to scrutinise improperly listed Orange Book patents could make these listings more important in litigation, but firms should be looking at this anyway
Counsel at Debevoise & Plimpton explain how they helped food delivery business Grubhub avoid a preliminary injunction at the Court of Appeals for the Seventh Circuit